The FDA granted an emergency authorization to a portable coronavirus antigen test developed by BD, similar to a rapid flu test, designed to allow hospitals, doctors’ offices, urgent care centers and retail pharmacies to examine a person showing symptoms in about 15 minutes. At the same time, the agency alerted healthcare providers of potential false-positive results from a separate BD laboratory diagnostic for COVID-19, which previously received an FDA green light in April.
